We are live on ! Find out more
AIM

ARGA Investment Management Portfolio holdings

AUM $3.05B
1-Year Est. Return 47.96%
This Fund
S&P 500
This Quarter Est. Return
+17.3%
1 Year Est. Return
+47.96%
3 Year Est. Return
+72.22%
5 Year Est. Return
+105.74%
10 Year Est. Return
+497.86%
AUM
$880M
AUM Growth
+$77.6M
Cap. Flow
-$48.2M
Cap. Flow %
-5.47%
Top 10 Hldgs %
80.17%
Holding
70
New
9
Increased
12
Reduced
22
Closed
13

Top Buys

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$26.9M
2
CTSH icon
Cognizant
CTSH
+$6.38M
3
BKR icon
Baker Hughes
BKR
+$2.46M
4
GILD icon
Gilead Sciences
GILD
+$1.9M
5
NXPI icon
NXP Semiconductors
NXPI
+$1.55M

Sector Composition

Rank Sector Weight
1 Technology 42.64%
2 Consumer Discretionary 15.27%
3 Financials 14.52%
4 Energy 8.45%
5 Materials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRI icon
1
Capri Holdings
CPRI
$1.77B
$129M 14.7%
3,391,415
-400,142
-11% -$13.8M
TSM icon
2
TSMC
TSM
$2.09T
$120M 13.62%
2,062,756
-322,145
-14% -$17.1M
IBN icon
3
ICICI Bank
IBN
$106B
$83.7M 9.5%
5,543,743
-169,818
-3% -$2.31M
NXPI icon
4
NXP Semiconductors
NXPI
$68B
$74.4M 8.45%
584,608
+13,328
+2% +$1.55M
CNQ icon
5
Canadian Natural Resources
CNQ
$96.9B
$70.9M 8.05%
4,475,237
-441,276
-9% -$6M
CTSH icon
6
Cognizant
CTSH
$21.5B
$70M 7.96%
1,129,226
+103,222
+10% +$6.38M
SIMO icon
7
Silicon Motion
SIMO
$9.19B
$63M 7.15%
1,241,953
-23,739
-2% -$1.02M
KLIC icon
8
Kulicke & Soffa
KLIC
$5.3B
$36.1M 4.1%
1,326,933
+368
+0% +$9.08K
CNH
9
CNH Industrial
CNH
$13.8B
$29.3M 3.33%
3,069,635
NTR icon
10
Nutrien
NTR
$32.7B
$29.1M 3.3%
606,910
+557,272
+1,123% +$26.9M
RNR icon
11
RenaissanceRe
RNR
$13.7B
$28.7M 3.26%
146,576
-49,763
-25% -$9.43M
BIDU icon
12
Baidu
BIDU
$35.8B
$27.9M 3.17%
220,878
+591
+0.3% +$67.2K
JOYY
13
JOYY Inc
JOYY
$3.73B
$20.3M 2.3%
384,146
SSL icon
14
Sasol
SSL
$7.58B
$18.9M 2.15%
876,252
+4,043
+0.5% +$77.3K
EWT icon
15
iShares MSCI Taiwan ETF
EWT
$10B
$8.54M 0.97%
207,766
ON icon
16
ON Semiconductor
ON
$33.8B
$5.45M 0.62%
223,621
-1,827
-0.8% -$38.6K
CVS icon
17
CVS Health
CVS
$137B
$5M 0.57%
67,279
GILD icon
18
Gilead Sciences
GILD
$161B
$4.41M 0.5%
67,876
+29,200
+75% +$1.9M
CNDT icon
19
Conduent
CNDT
$230M
$4.38M 0.5%
706,562
-43,912
-6% -$275K
C icon
20
Citigroup
C
$222B
$3.86M 0.44%
48,325
-9,438
-16% -$697K
INDA icon
21
iShares MSCI India ETF
INDA
$6.71B
$3.79M 0.43%
107,869
VTRS icon
22
Viatris
VTRS
$20.1B
$3.65M 0.42%
181,721
-822
-0.5% -$15.3K
BAC icon
23
Bank of America
BAC
$435B
$3.54M 0.4%
100,460
-26,919
-21% -$870K
IEMG icon
24
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$2.92M 0.33%
54,249
-31,425
-37% -$1.62M
BEN icon
25
Franklin Resources
BEN
$16.9B
$2.81M 0.32%
108,050

Similar funds

ARGA Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, ARGA Investment Management held 70 positions worth $880M, up 9.7% from $803M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

ARGA Investment Management withdrew a net $48.2M in Q4 2019, closing 13 positions and reducing 22 holdings. Its most notable exit was Petrobras Class A, an estimated $22.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, ARGA Investment Management opened a new position in Baker Hughes worth $2.77M.

  • ARGA Investment Management's largest Q4 2019 buy was Baker Hughes: 108,108 shares worth $2.77M.
  • ARGA Investment Management added most to Nutrien in Q4 2019, an estimated $26.9M increase.
  • ARGA Investment Management's biggest Q4 2019 reduction was TSMC, cutting an estimated $17.1M.
  • ARGA Investment Management fully exited Petrobras Class A in Q4 2019, selling an estimated $22.3M.
  • ARGA Investment Management's ten largest holdings make up 80% of its $880M portfolio in Q4 2019.
  • ARGA Investment Management opened 9 new positions and closed 13 in Q4 2019.
  • ARGA Investment Management's portfolio value rose 9.7% quarter-over-quarter to $880M.

Based on ARGA Investment Management's 13F filing for Q4 2019, filed 31 Jan 2020.